Management of guillain-barré syndrome-an autoimmune disorder: A review.

Simple item page
dc.contributor.authorRaghvendra
dc.contributor.authorTyagi, Satyanand
dc.contributor.authorYadav, Pramod
dc.contributor.authorSaxena, Sunanda
dc.date.accessioned2015-06-20T08:37:15Z
dc.date.available2015-06-20T08:37:15Z
dc.date.issued2010-08
dc.description.abstractGuillain-Barré syndrome is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances, the weakness and abnormal sensations spread to the arms and upper body. There is no known cure for Guillain-Barré syndrome, but therapies can lessen the severity of the illness and accelerate the recovery in most patients. There are also a number of ways to treat the complications of the disease. Currently, plasmapheresis and high-dose immunoglobulin therapy are used. Plasmapheresis seems to reduce the severity and duration of the Guillain-Barré episode. In high-dose immunoglobulin therapy, doctors give intravenous injections of the proteins that in small quantities, the immune system uses naturally to attack invading organism. The most critical part of the treatment for this syndrome consists of keeping the patient's body functioning during recovery of the nervous system. This can sometimes require placing the patient on a respirator, a heart monitor, or other machines that assist body function. The aim of present article is to provide in depth knowledge about Guillain-Barré syndrome which is no doubt, a rare autoimmune disorder. In this article the author has explained all the clinical aspects related to Guillain-Barré syndrome. This article presents a brief review of Guillain-Barré syndrome with an emphasis on its possible management and therapies.en_US
dc.identifier.citationRaghvendra, Tyagi Satyanand, Yadav Pramod, Saxena Sunanda. Management of guillain-barré syndrome-an autoimmune disorder: A review. International Journal of Applied Biology and Pharmaceutical Technology. 2010 Aug-Oct; 1(2): 722-728.en_US
dc.identifier.issn0976-4550
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/158144
dc.language.isoenen_US
dc.source.urihttps://www.ijabpt.com/pdf/8068-Satya%20Tyagi[2].pdfen_US
dc.subjectAutoimmune Disorderen_US
dc.subjectGuillain–Barré syndromeen_US
dc.subjectGBSen_US
dc.subjectAIDPen_US
dc.subjectLandry's paralysisen_US
dc.subjectperipheral neuropathiesen_US
dc.titleManagement of guillain-barré syndrome-an autoimmune disorder: A review.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijabpt2010v1n2p722.pdf
Size:
200.86 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
International Journal of Applied Biology and Pharmaceutical Technology